Tentarix Biotherapeutics Strengthens Executive Team [Yahoo! Finance]
Vaxcyte, Inc. (PCVX)
Company Research
Source: Yahoo! Finance
active multispecific biologics, today announced four key executive changes that further strengthen its executive team and capabilities as it advances a differentiated pipeline into development. Ash Khanna, Ph.D. , joins as Chief Business Officer; Dallas Jones, Ph.D. , as Senior Vice President, Biology; and Tim Noffke as Vice President, Program Management and Chief of Staff. The Company also announced the promotion of Ankita Srivastava, Ph.D. , to Senior Vice President, Biotherapeutics. "We are thrilled to welcome Ash, Dallas, and Tim to the team and to recognize Ankita's outstanding contributions with this well-deserved promotion," said Andy Kidd, M.D., Chief Executive Officer of Tentarix. "Together, their complementary expertise in business development, translational biology, biologics engineering, and development-stage execution strengthens our ability to accelerate a highly differentiated pipeline of conditional multispecific biologics into the clinic and ultimately deliver meani
Show less
Read more
Impact Snapshot
Event Time:
PCVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PCVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PCVX alerts
High impacting Vaxcyte, Inc. news events
Weekly update
A roundup of the hottest topics
PCVX
News
- Vaxcyte (PCVX): Evaluating Valuation After a 48% Three-Month Share Price Rebound [Yahoo! Finance]Yahoo! Finance
- Vaxcyte (NASDAQ:PCVX) was given a new $77.00 price target on by analysts at Leerink Partners.MarketBeat
- Medicxi Announces €500 Million Fund V [Yahoo! Finance]Yahoo! Finance
- Medicxi closes fifth fund to back ‘asset-centric' startups [Yahoo! Finance]Yahoo! Finance
- Vaxcyte (NASDAQ:PCVX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $85.00 price target on the stock.MarketBeat
PCVX
Earnings
- 11/4/25 - Miss
PCVX
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- 11/4/25 - Form 10-Q
- PCVX's page on the SEC website